Search
for
Sort by
Research 601–630 of 1000+
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Clinicoepidemiological profile, precipitating factors and severity indicators in alopecia areata in Manipur
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Vitamin B <sub>12</sub> Deficiency: A Rare Cause of Excessive Daytime Sleepiness
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Vitamin A toxicity: When one a day doesn't keep the doctor away
- Alopecia areata universalis showing excellent response to combination treatment modalities
- Excimer Laser: A Module of the Alopecia Areata Common Protocol
- Lower Extremity Cramping and Palpitations in a 17-Year-Old Boy
- EHRLICHIOSIS AND DEMODICOSIS IN BALI LOCAL DOG
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Alopecia universalis successfully treated with tofacitinib
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Alopecia Areata of the Nails: Diagnosis and Management
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Bempikibart shows its potential for hair regrowth in alopecia areata
- Minoxidil for Control of Acute Blood Pressure Elevation in Chronically Hypertensive Children
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Treatment and Long-Term Outcome of COVID-19 Disease in Children with Inborn Errors of Immunity (IEI): Does Hematopoietic Stem Cell Transplantation (HSCT) Have a Protective Effect?
- Ovarian Hyperthecosis Presenting as Polycythemia